Anika Therapeutics Inc. · NASDAQ:ANIK
Griffin Stephen D. exercised options for 12,840 Anika Therapeutics Inc. shares (Form 4)
Traded Jun 3, 2026 · Filed Jun 5, 2026
On Jun 3, 2026, Griffin Stephen D. (Director, President and CEO) exercised options for 12,840 Anika Therapeutics Inc. shares, leaving 45,973 shares. Filed Jun 5, 2026 (Form 4).
- Options exercised
- 12,840 shares
- Holding after
- 45,973 shares
- Trading plan
- No
- Role
- Director, President and CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 3, 2026 | Common Stock | Option exercise | 12,840 | 49,742 | Direct | |
| Jun 3, 2026 | Common Stock | Shares withheld for tax | 3,769 | US$14.41 | 45,973 | Direct |
Source
Related
- Anika Therapeutics Inc.
- Griffin Stephen D.
- Anika Therapeutics Inc. shareholders
- Form 4 · Griffin Stephen D. · Apr 30, 2026
- Form 4 · Fischetti Gary P · Aug 5, 2026
- Schedule 13G/A · Vanguard Capital Management LLC · Jul 31, 2026
- Schedule 13G/A · BlackRock Portfolio Management LLC · Jul 17, 2026
- Form 4 · Fischetti Gary P · Jun 23, 2026
- Form 4 · Henneman John B III · Jun 23, 2026